President Trump heralded a drug-pricing agreement with Regeneron, closing the last of 17 deals sought by the White House ...

A multiple sclerosis drug from Sanofi that was rejected late last year by the FDA found a warmer reception in Europe.

In today's Morning Rounds newsletter, a new era in GOP drug policy, an international childhood vaccine campaign grows, and ...

Since I was 7, my goal has been to become a doctor. But life had other plans. I grew up in a blue-collar family in Levittown, ...

The problematic use of guest editors was spotlighted last week when a genetics journal retracted nearly an entire special ...

Gazette, Western Pennsylvania’s largest news organization, announced it would cease publication on May 3 after nearly 240 ...

In this week’s STATus Report, host Alex Hogan chats with STAT Washington correspondent Daniel Payne about Trump's ...

WASHINGTON — President Trump heralded a drug pricing agreement with Regeneron on Thursday, closing the last of 17 deals ...

The Trump administration, in a stark departure from the "Just Say No" era, is funding psychedelics research and rescheduling ...

On Tuesday, Secretary of Defense Pete Hegseth announced that the men and women who defend our nation will be able to choose ...

This week on "The Readout LOUD": a CAR-T biotech's dramatic turnaround, and drugmakers' tactics to drive more scripts. Listen ...

The constant pressure that the heart is under from beating thousands of times a day may create an environment hostile to ...